Related Experiment Video
Updated: Jun 13, 2026

Non-Intubated Video-Assisted Thoracoscopic Surgery
Published on: May 26, 2023
Regional anaesthesia and anticoagulation
1Department of Anaesthesiology, University Hospitals Leuven, Katholieke Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium. erik.vandermeulen@uzleuven.be
Insights
Antithrombotic drug use increases spinal haematoma risk during central neuraxial anaesthesia. This review covers guidelines for regional anaesthesia with anticoagulants and strategies for new antithrombotic agents.
Area of Science:
- Anesthesiology
- Cardiology
- Pharmacology
Background:
- Increasing life expectancy leads to higher cardiovascular disease prevalence and antithrombotic drug use.
- Central neuraxial anaesthesia in patients on antithrombotics poses risks due to impaired coagulation and spinal haematoma formation.
- Rising spinal haematoma cases have prompted national anaesthetist societies to develop guidelines.
Purpose of the Study:
- To provide an overview of current guidelines for regional anaesthesia in patients using anticoagulants.
- To outline a strategy for managing new antithrombotic drugs in anaesthetic practice.
Main Methods:
- Review of current national guidelines on regional anaesthesia and anticoagulation.
- Analysis of risk factors for spinal haematoma.
- Discussion of management strategies for novel antithrombotic agents.
Main Results:
- Central neuraxial anaesthesia in patients on antithrombotics is a significant clinical challenge.
- Impaired coagulation is a primary risk factor for spinal haematoma.
- Existing guidelines address various anticoagulants, but new drugs require specific management strategies.
Conclusions:
- Guidelines for regional anaesthesia in patients on antithrombotics are essential for patient safety.
- A proactive strategy is needed to manage the risks associated with new antithrombotic drugs during anaesthesia.
- Further research and guideline updates are necessary to address evolving antithrombotic therapies.
Abstract:
As the life expectancy of our Western population progressively increases, so does the prevalence of cardiovascular disease and thus the use of antithrombotic drugs. The use of central neuraxial anaesthesia techniques in patients treated with these drugs is a major clinical problem as the presence of an impaired coagulation has been found to be the most important risk factor contributing to the formation of a spinal haematoma. The growing number of case reports of spinal haematoma has led many national societies of anaesthetists to come up with guidelines. This article presents an overview of current guidelines on the use of regional anaesthetic techniques in patients treated with various anticoagulants and also describes a possible strategy to deal with new antithrombotic drugs that have recently been introduced in some countries or will be shortly in others.
Related Concept Videos
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
Local Anesthetics: Pharmacokinetics
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...

